A phase 2 study of the efficacy and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent myelodysplastic syndromes

Mise à jour : Il y a 4 ans
Référence : ISRCTN62162141

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

http://www.cancerresearchuk.org/cancer-help/trials/a-study-looking-drug-deferasirox-people-myelodysplastic-syndromes-de-iron


Critère d'inclusion

  • Topic: National Cancer Research Network, Blood; Subtopic: Haematological Oncology, Blood (all Subtopics); Disease: Unknown Primary Site, Non-malignant haematology

Liens